Home/Filings/4/0000899243-22-025472
4//SEC Filing

Templeman Thomas 4

Accession 0000899243-22-025472

CIK 0001847903other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 6:15 PM ET

Size

5.4 KB

Accession

0000899243-22-025472

Insider Transaction Report

Form 4
Period: 2022-07-01
Templeman Thomas
Chief Technology Officer
Transactions
  • Award

    Ordinary Shares

    2022-07-01+140,000140,250 total
Footnotes (2)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in 10 equal quarterly instalments with the first such quarterly vesting being on September 30, 2022.

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

Entity typeother

Related Parties

1
  • filerCIK 0001654274

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:15 PM ET
Size
5.4 KB